Syndax Pharmaceuticals Inc
NASDAQ:SNDX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12.85
24.81
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Syndax Pharmaceuticals Inc
Wall Street
Price Targets
SNDX Price Targets Summary
Syndax Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
SNDX
is 37.23 USD
with a low forecast of 18.18 USD and a high forecast of 53.55 USD.
SNDX Last Price Targets
Syndax Pharmaceuticals Inc
The latest public price target was made on Nov 13, 2024 by
George Farmer
from
Scotiabank
,
who expects
SNDX
stock to
rise by 38%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
George Farmer
Scotiabank
|
18
USD
Upside 38% |
1 month ago
Nov 13, 2024
|
Syndax Pharmaceuticals (SNDX) PT Lowered to $18 at Scotiabank
StreetInsider
|
David Dai
UBS
|
37
USD
Upside 183% |
1 month ago
Oct 24, 2024
|
UBS Starts Syndax Pharmaceuticals (SNDX) at Buy
StreetInsider
|
Peter Lawson
Barclays
|
33
USD
Upside 152% |
4 months ago
Aug 15, 2024
|
Syndax price target raised to $33 from $32 at Barclays
TheFly
|
Jason Zemansky
Bank of America Securities
|
31
USD
Upside 137% |
4 months ago
Aug 15, 2024
|
Syndax price target raised to $31 from $30 at BofA
TheFly
|
Yigal Nochomovitz
Citigroup
|
34
USD
Upside 160% |
4 months ago
Aug 15, 2024
|
Syndax Pharmaceuticals (SNDX) PT Raised to $34 at Citi
StreetInsider
|
|
Jason Zemansky
Bank of America Securities
|
30
USD
Upside 129% |
4 months ago
Jul 30, 2024
|
Syndax Pharmaceuticals (SNDX) PT Lowered to $30 at BofA Securities
StreetInsider
|
Kelly Shi
Jefferies
|
37
USD
Upside 183% |
5 months ago
Jun 28, 2024
|
Jefferies Starts Syndax Pharmaceuticals (SNDX) at Buy
StreetInsider
|
Bradley Canino
Stifel Nicolaus
|
40
USD
Upside 206% |
7 months ago
May 9, 2024
|
Syndax Pharmaceuticals (SNDX) PT Raised to $40 at Stifel
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SNDX's stock price target?
Price Target
37.23
USD
According to Wall Street analysts, the average 1-year price target for
SNDX
is 37.23 USD
with a low forecast of 18.18 USD and a high forecast of 53.55 USD.
You don't have any saved screeners yet
